Noventra Pharma|Tirzepatide 30mg|Compound Peptide Pen
High-Strength Dual Incretin Metabolic Research Compound
Tirzepatide is an investigational peptide studied for its dual receptor activity across GLP-1 and GIP pathways.
It is widely referenced in scientific research exploring incretin signalling, metabolic regulation mechanisms, and peptide-receptor interaction pathways.
Developed as a 30mg research compound, this formulation is designed for controlled laboratory investigation where metabolic signalling and receptor activity profiling are of interest.
Key Benefits – Noventra Pharma Tirzepatide Research Compound Peptide Pen 30mg
• Dual GIP and GLP-1 receptor research compound
• Investigated in incretin pathway and metabolic signalling research models
• Of interest in peptide receptor interaction studies
• 30mg research formulation for controlled laboratory use
• Studied in metabolic and endocrine research contexts
• Pre-filled pen format designed for consistent laboratory handling
• High-purity compounded formulation from Noventra Pharma
• Manufactured for stability, consistency, and research reliability
⚖️ DISCLAIMER
This product is intended strictly for laboratory research purposes only. It is not a medicine and has not been evaluated or approved by the South African Health Products Regulatory Authority (SAHPRA) for human or animal use.
This product is supplied strictly for laboratory research purposes only and is not intended for human consumption.
Products sold on this website are not intended to diagnose, treat, cure, or prevent any disease.
By purchasing, the customer confirms they are qualified to handle and use this product in accordance with applicable laws and regulations.
